The Cancer Prevention and Research Institute of Texas awarded 60 new academic research, centered around cancer prevention, and product development research grants totaling more than $102 million.CPRIT has awarded 1,189 grants totaling more than $1.89 billion. The agency began making awards in 2009 after Texas voters overwhelmingly approved a 2007 constitutional amendment committing $3 billion to the fight against cancer. Fifty-one of the awards, totaling more than $79 million, went to academic research grants/ Eight prevention services grants were awarded totaling $14 million, as well as one product development research grant for $9 million.“The large number of awards approved by CPRIT underlies the growth of the cancer-fighting ecosystem in Texas,” said Wayne Roberts, CPRIT chief executive officer. “This momentum is evident as Texas expands its critical mass of talent in our life-sciences sector.”
In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).Â
